Credit Suisse Maintains Neutral on Johnson & Johnson, Raises Price Target to $175
Portfolio Pulse from richadhand@benzinga.com
Credit Suisse analyst Trung Huynh has maintained a Neutral rating on Johnson & Johnson (NYSE:JNJ) and raised the price target from $170 to $175.
July 21, 2023 | 11:40 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson's price target has been raised from $170 to $175 by Credit Suisse, while maintaining a Neutral rating.
The news is directly about Johnson & Johnson. The raised price target indicates a positive outlook, but the Neutral rating suggests that the stock is fairly valued at the moment. This could lead to a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100